Presentation TCT 2014 A Rational Approach for Stent Selection in ACS: BMS vs Metallic DES vs BRS Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Huay Cheem Tan September 16, 2014
Presentation TCT 2014 Country by Country Variation in STEMI Management and Outcomes: Latest Stent for Life Data Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Petr Kala September 16, 2014
Presentation TCT 2014 Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction Presenter: Carlo Di Mario September 16, 2014
Presentation TCT 2014 Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___ Presenter: Georgios Vlachojannis September 16, 2014
Presentation TCT 2014 A Real-World Single Centre Experience Using The Self?Expanding Coronary Stent Presenter: Luca Mariani September 16, 2014
Presentation TCT 2014 Comparison of Novel Zotarolimus-Eluting Cobalt-Chromium Stents and Everolimus-Eluting Platinum-Chromium Stents in Patients of the Randomized DUTCH PEERS Trial Presenting with___ Presenter: Marije L?wik September 16, 2014
Presentation TCT 2014 Real world comparison of MGuard stent versus bare metal stent for ST elevation myocardial infartion Presenter: Agust?n Fernandez-Cisnal September 16, 2014
Presentation TCT 2014 Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_ Presenter: Krishnankutty Sudhir September 16, 2014
Presentation TCT 2014 Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___ Presenter: Georgios Vlachojannis September 16, 2014
Presentation TCT 2014 TCT 17: Direct Versus Conventional Stenting in ST-Elevation Myocardial Infarction: A Systematic Review and Meta-analysis Presenter: John A. Bittl, Tullio Palmerini, Lorenzo Azzalini, MD September 15, 2014
News Conference News TCT 2014 EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion September 14, 2014
Presentation TCT 2014 Stent Designs and STEMI: Are There Meaningful Differences? Presenter: Luigi Salemme, Mohamed Sobhy, Carlo Briguori September 13, 2014
Presentation TCT 2014 HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction Presenter: Patrick W. Serruys, George D. Dangas September 13, 2014
Presentation TCT 2014 Case #2: Stenting Nonculprit Lesions in STEMI: Right or Wrong? Presenter: Dan Deleanu, Dariusz Dudek, Robert J. Gil, Greg L. Kaluza, Andrzej J. Ochala, Marin Postu September 13, 2014
News Conference News TCT 2014 Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI September 13, 2014
News Daily News Las PCI Solo del Vaso Causante Podrían ser Mejores en Pacientes IM con Enfermedad Multivaso y Shock Cardiogénico September 11, 2014
News Daily News Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock September 11, 2014
News Daily News Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados September 02, 2014
News Conference News ESC 2014 IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI Todd Neale September 02, 2014
News Daily News HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes September 02, 2014